In the News | Friends of Cancer Research

You are here

In the News

September 28, 2018
Senators Hatch and Bennet Introduce Bipartisan Solution to Important Public Health Issue September 28, 2018 – Washington, DC – Friends of Cancer Research (Friends) applauds Senators Orrin Hatch (R-UT... Read more
September 28, 2018
A bipartisan duo of senators wants to give the Food and Drug Administration the power to add off-label uses to certain generic drug labels.   Sens. Orrin Hatch (R-Utah) and Michael Bennet (D-Colo.)... Read more
September 26, 2018
Real-life studies have become increasingly important in the scientific world in recent years. Although they have numerous limitations, they have the advantage of better representing the population... Read more
September 26, 2018
The Oregon Health Authority is weighing a recommendation to deny Medicaid coverage for next-generation sequencing tests in the state.   If enacted, Oregonians who rely on Medicaid for cancer... Read more
September 25, 2018
On August 8, ASCO and Friends of Cancer Research (Friends) submitted recommended language to the U.S. Food and Drug Administration (FDA) for five guidance documents on ways to broaden eligibility... Read more
September 18, 2018
September 18, 2018 – Washington, DC – Today, Friends of Cancer Research (Friends) announced the launch of Phase II of its tumor mutational burden or TMB Harmonization Project as the TMB harmonization... Read more
September 17, 2018
Commissioner Scott Gottlieb is scaling up FDA efforts to assert control over laboratory developed tests, saying in a speech that the agency would take a flexible approach — but first needs the power... Read more
September 17, 2018
FDA’s recent proposal to establish “a collaborative community” of stakeholders to support the agency in its decision-making process for diagnostics regulation could also serve as “a compelling new... Read more
September 14, 2018
A potential resolution to a lingering debate on how the government should oversee laboratory-developed diagnostic tests would focus the FDA’s attention on the more cutting-edge and riskier screening... Read more
September 14, 2018
The American Society of Clinical Oncology proposed four ways to lower financial barriers that impede cancer patients' ability to participate in clinical trials, including a recommendation to improve... Read more

Pages